Tuesday, September 25, 2018
 
 
Company News: Page (1) of 1 - 08/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
 
(August 16, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Diet,Disease,Aging,medical technologists,Surgery,Science,Communications Technology,Medical,Cancer,Science,Adults,Family,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • ChenMed to Invest More Than $200 Million to Bring Affordable Concierge-Style Health Care to Philadelphia Seniors
  • $724 Million Viral Clearance Market by Application, End User, Method, Viral Inactivation - Global Forecasts to 2023
  • Global Viral Clearance Market 2018-2023 - Increasing Pharmaceutical Outsourcing & Emerging Markets Offer Opportunities
  • Global Automated Biochemistry Analyzers Market 2018-2022 - Increasing Use of Biochemical Tests for Pregnancy-Related Issues
  • The viral clearance market is projected to grow at a CAGR of 21.7%

    Cancer
  • Rose Medical Center's Cancer Program Re-Accredited by the Commission on Cancer
  • Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
  • GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines